OPKO Health, Inc. (OPK)
NASDAQ: OPK · IEX Real-Time Price · USD
1.260
+0.040 (3.28%)
At close: Apr 26, 2024, 4:00 PM
1.250
-0.010 (-0.79%)
After-hours: Apr 26, 2024, 7:42 PM EDT
OPKO Health Revenue
In the year 2023, OPKO Health had annual revenue of $863.50M, a decrease of -14.01%. Revenue in the quarter ending December 31, 2023 was $181.90M, a -1.85% decrease year-over-year.
Revenue (ttm)
$863.50M
Revenue Growth
-14.01%
P/S Ratio
1.02
Revenue / Employee
$219,719
Employees
3,930
Market Cap
878.21M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
Dec 31, 2018 | 990.27M | 24.26M | 2.51% |
Dec 31, 2017 | 966.01M | -151.49M | -13.56% |
Dec 31, 2016 | 1.12B | 625.76M | 127.25% |
Dec 31, 2015 | 491.74M | 400.61M | 439.63% |
Dec 31, 2014 | 91.13M | -5.41M | -5.60% |
Dec 31, 2013 | 96.53M | 49.49M | 105.19% |
Dec 31, 2012 | 47.04M | 19.07M | 68.14% |
Dec 31, 2011 | 27.98M | -515.00K | -1.81% |
Dec 31, 2010 | 28.49M | 24.08M | 544.95% |
Dec 31, 2009 | 4.42M | -5.02M | -53.20% |
Dec 31, 2008 | 9.44M | 8.59M | 1,014.52% |
Dec 31, 2007 | 847.00K | - | - |
Dec 31, 2006 | 0 | - | - |
Dec 31, 2005 | 0 | - | - |
Dec 31, 2004 | 0 | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 0 | - | - |
Dec 31, 2001 | 0 | - | - |
Dec 31, 2000 | 0 | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 0 | - | - |
Dec 31, 1996 | 0 | - | - |
Dec 31, 1995 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avanos Medical | 673.30M |
Artivion | 354.00M |
BioCryst Pharmaceuticals | 331.41M |
MiMedx Group | 321.48M |
Simulations Plus | 64.67M |
MacroGenics | 58.75M |
Relay Therapeutics | 25.55M |
Perspective Therapeutics | 1.43M |
OPK News
- 4 weeks ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business - PRNewsWire
- 7 weeks ago - AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV - GlobeNewsWire
- 2 months ago - OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 - GlobeNewsWire
- 3 months ago - OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes - GlobeNewsWire
- 4 months ago - OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 - GlobeNewsWire
- 4 months ago - OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029 - GlobeNewsWire
- 5 months ago - BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing - PRNewsWire